ResMed Inc. (RMD)
NYSE: RMD · IEX Real-Time Price · USD
189.35
+2.41 (1.29%)
At close: Jul 2, 2024, 4:00 PM
190.73
+1.38 (0.73%)
After-hours: Jul 2, 2024, 7:46 PM EDT

ResMed Revenue

ResMed had revenue of $4.58B in the twelve months ending March 31, 2024, with 14.16% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.20B with 7.17% year-over-year growth. In the fiscal year ending June 30, 2023, ResMed had annual revenue of $4.22B with 18.02% growth.

Revenue (ttm)
$4.58B
Revenue Growth
+14.16%
P/S Ratio
6.07
Revenue / Employee
$452,087
Employees
10,140
Market Cap
27.82B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20234.22B644.87M18.02%
Jun 30, 20223.58B381.30M11.93%
Jun 30, 20213.20B239.81M8.11%
Jun 30, 20202.96B350.44M13.44%
Jun 30, 20192.61B266.38M11.38%
Jun 30, 20182.34B273.46M13.23%
Jun 30, 20172.07B228.02M12.40%
Jun 30, 20161.84B159.80M9.52%
Jun 30, 20151.68B123.94M7.97%
Jun 30, 20141.55B40.52M2.68%
Jun 30, 20131.51B145.94M10.66%
Jun 30, 20121.37B125.37M10.08%
Jun 30, 20111.24B150.79M13.80%
Jun 30, 20101.09B171.62M18.64%
Jun 30, 2009920.74M85.34M10.22%
Jun 30, 2008835.40M119.07M16.62%
Jun 30, 2007716.33M109.34M18.01%
Jun 30, 2006607.00M181.49M42.65%
Jun 30, 2005425.51M86.17M25.39%
Jun 30, 2004339.34M65.77M24.04%
Jun 30, 2003273.57M69.49M34.05%
Jun 30, 2002204.08M48.92M31.53%
Jun 30, 2001155.16M39.54M34.20%
Jun 30, 2000115.62M26.99M30.45%
Jun 30, 199988.63M22.11M33.24%
Jun 30, 199866.52M17.34M35.26%
Jun 30, 199749.18M14.62M42.30%
Jun 30, 199634.56M11.06M47.07%
Jun 30, 199523.50M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cardinal Health 220.57B
Centene 155.52B
Koninklijke Philips 20.19B
Biogen 9.66B
ICON PLC 8.23B
Mettler-Toledo International 3.79B
West Pharmaceutical Services 2.93B
Veeva Systems 2.49B
Revenue Rankings